AVE1625: Clinical Trials

1 trial of AVE1625, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow AVE1625: new trials by email Literature Review of AVE1625 trials Research Report on AVE1625

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.
AVE1625 - Alzheimer Disease
Phase 1 / Phase 2CompletedSanofi1622006-09-012008-12-19

Conditions studied

Alzheimer Disease (1)

Sponsors

Sanofi (1)

Countries

France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United States (1)